TransMedics (TMDX) Net Income (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.63% |
| Dec 31, 2025 | -23.63% |
| Sep 30, 2025 | -30.25% |
| Jun 30, 2025 | 35.85% |
| Mar 31, 2025 | 263.01% |
| Dec 31, 2024 | 67.77% |
| Sep 30, 2024 | -65.43% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -58.52% |
| Dec 31, 2023 | 215.65% |
| Sep 30, 2023 | -2,439.66% |
| Jun 30, 2023 | 62.03% |
| Mar 31, 2023 | 60.77% |
| Dec 31, 2022 | 9.51% |
| Sep 30, 2022 | 35.55% |
| Jun 30, 2022 | -9.10% |
| Mar 31, 2022 | -133.37% |
| Dec 31, 2021 | 344.20% |
| Sep 30, 2021 | -21.50% |
| Jun 30, 2021 | -34.75% |
| Mar 31, 2021 | -135.20% |
| Dec 31, 2020 | 542.06% |
| Sep 30, 2020 | 40.12% |
| Jun 30, 2020 | 4.01% |
| Mar 31, 2020 | -136.08% |
| Dec 28, 2019 | 396.27% |
| Sep 28, 2019 | 9.95% |
| Jun 29, 2019 | -33.36% |
| Mar 30, 2019 | 9.69% |
| Dec 29, 2018 | -49.56% |
| Sep 29, 2018 | 16.52% |
| Jun 30, 2018 | -24.77% |